A Novel Phytotherapy Application: Preparation, Characterization, Antioxidant Activities and Determination of Anti-inflammatory Effects by In vivo HET-CAM Assay of Chitosan-based DDSs Containing Endemic Helichrysum pamphylicum P.H. Davis & Kupicha Methanolic Extract.

IF 2.8 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Nurlan Ismailovi, H Tuba Kıyan, A Alper Öztürk
{"title":"A Novel Phytotherapy Application: Preparation, Characterization, Antioxidant Activities and Determination of Anti-inflammatory Effects by <i>In vivo</i> HET-CAM Assay of Chitosan-based DDSs Containing Endemic <i>Helichrysum pamphylicum</i> P.H. Davis & Kupicha Methanolic Extract.","authors":"Nurlan Ismailovi, H Tuba Kıyan, A Alper Öztürk","doi":"10.2174/1567201820666230328122504","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Numerous pharmaceutical applications for chitosan, a polysaccharide made from the shells of crustaceans by deacetylating chitin that occurs naturally, are currently being researched. Chitosan, a natural polymer, is successfully used to prepare many drug-carrier systems, such as gel, film, nanoparticle, and wound dressing.</p><p><strong>Objective: </strong>Preparing chitosan gels without external crosslinkers is less toxic and environmentally friendly.</p><p><strong>Methods: </strong>Chitosan-based gels containing <i>Helichrysum pamphylicum</i> P.H. Davis & Kupicha methanolic extract (HP) were produced successfully.</p><p><strong>Results: </strong>The F9-HP coded gel prepared with high molecular weight chitosan was chosen as the optimum formulation in terms of pH and rheological properties. The amount of HP was found to be 98.83% ± 0.19 in the F9-HP coded formulation. The HP release from the F9-HP coded formula was determined to be slower and 9 hours prolonged release compared to pure HP. It was determined that HP release from F9-HP coded formulation with the DDSolver program was by anomalous (non-fickian) diffusion mechanism. The F9-HP coded formulation significantly showed DPPH free radical scavenger, ABTS•+ cation decolorizing and metal chelating antioxidant activity while weakly reducing antioxidant potential. According to the HET-CAM scores, strong anti-inflammatory activity was obtained by the F9-HP coded gel at a dose of 20 μg.embryo<sup>-1 </sup>(p<0.05 compared with SDS).</p><p><strong>Conclusion: </strong>In conclusion, it can be said that chitosan-based gels containing HP, which can be used in both antioxidant and anti-inflammatory treatment, were successfully formulated and characterized.</p>","PeriodicalId":10842,"journal":{"name":"Current drug delivery","volume":" ","pages":"901-916"},"PeriodicalIF":2.8000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11071655/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug delivery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/1567201820666230328122504","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Numerous pharmaceutical applications for chitosan, a polysaccharide made from the shells of crustaceans by deacetylating chitin that occurs naturally, are currently being researched. Chitosan, a natural polymer, is successfully used to prepare many drug-carrier systems, such as gel, film, nanoparticle, and wound dressing.

Objective: Preparing chitosan gels without external crosslinkers is less toxic and environmentally friendly.

Methods: Chitosan-based gels containing Helichrysum pamphylicum P.H. Davis & Kupicha methanolic extract (HP) were produced successfully.

Results: The F9-HP coded gel prepared with high molecular weight chitosan was chosen as the optimum formulation in terms of pH and rheological properties. The amount of HP was found to be 98.83% ± 0.19 in the F9-HP coded formulation. The HP release from the F9-HP coded formula was determined to be slower and 9 hours prolonged release compared to pure HP. It was determined that HP release from F9-HP coded formulation with the DDSolver program was by anomalous (non-fickian) diffusion mechanism. The F9-HP coded formulation significantly showed DPPH free radical scavenger, ABTS•+ cation decolorizing and metal chelating antioxidant activity while weakly reducing antioxidant potential. According to the HET-CAM scores, strong anti-inflammatory activity was obtained by the F9-HP coded gel at a dose of 20 μg.embryo-1 (p<0.05 compared with SDS).

Conclusion: In conclusion, it can be said that chitosan-based gels containing HP, which can be used in both antioxidant and anti-inflammatory treatment, were successfully formulated and characterized.

一种新的植物疗法应用:壳聚糖基 DDSs 的制备、表征、抗氧化活性以及通过体内 HET-CAM 分析确定其抗炎效果,其中含有当地特有的 Helichrysum pamphylicum P.H. Davis & Kupicha 代谢提取物。
背景:壳聚糖是从甲壳类动物的甲壳中通过脱乙酰化天然存在的甲壳素而制成的一种多糖,目前正在研究壳聚糖的许多药物应用。壳聚糖是一种天然聚合物,已成功用于制备多种药物载体系统,如凝胶、薄膜、纳米粒子和伤口敷料:目标:制备壳聚糖凝胶时无需外加交联剂,毒性较低且对环境友好:方法:成功制备了含有Helichrysum pamphylicum P.H.Davis & Kupicha甲醇提取物(HP)的壳聚糖凝胶:结果:使用高分子量壳聚糖制备的 F9-HP 编码凝胶在 pH 值和流变特性方面被选为最佳配方。在 F9-HP 编码配方中,HP 的含量为 98.83 %± 0.19。经测定,F9-HP 编码配方中 HP 的释放速度较慢,与纯 HP 相比,释放时间延长了 9 小时。通过 DDSolver 程序确定,F9-HP 编码配方的 HP 释放是通过反常(非费克)扩散机制进行的。F9-HP 编码配方具有明显的 DPPH 自由基清除剂、ABTS-+ 阳离子脱色和金属螯合抗氧化活性,同时具有微弱的还原抗氧化潜力。根据 HET-CAM 评分,F9-HP 编码凝胶在剂量为 20 µg.embryo-1 时具有较强的抗炎活性(pConclusion):总之,可以说含有 HP 的壳聚糖基凝胶已成功配制并定性,可用于抗氧化和抗炎治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current drug delivery
Current drug delivery PHARMACOLOGY & PHARMACY-
CiteScore
5.10
自引率
4.20%
发文量
170
期刊介绍: Current Drug Delivery aims to publish peer-reviewed articles, research articles, short and in-depth reviews, and drug clinical trials studies in the rapidly developing field of drug delivery. Modern drug research aims to build delivery properties of a drug at the design phase, however in many cases this idea cannot be met and the development of delivery systems becomes as important as the development of the drugs themselves. The journal aims to cover the latest outstanding developments in drug and vaccine delivery employing physical, physico-chemical and chemical methods. The drugs include a wide range of bioactive compounds from simple pharmaceuticals to peptides, proteins, nucleotides, nucleosides and sugars. The journal will also report progress in the fields of transport routes and mechanisms including efflux proteins and multi-drug resistance. The journal is essential for all pharmaceutical scientists involved in drug design, development and delivery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信